Cargando…
Hopamine as Personalized Medicine for Persons with Parkinson’s Disease
Prescribing dopamine replacement therapy remains the most common approach used by physicians who strive to support persons with Parkinson’s disease. In this viewpoint, we argue that instead of merely prescribing dopamine, healthcare professionals should particularly encourage and enable persons with...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041418/ https://www.ncbi.nlm.nih.gov/pubmed/36806516 http://dx.doi.org/10.3233/JPD-230012 |
_version_ | 1784912713121529856 |
---|---|
author | Noordegraaf, Marina A. van den Berg, Sanne W. Bloem, Bastiaan R. |
author_facet | Noordegraaf, Marina A. van den Berg, Sanne W. Bloem, Bastiaan R. |
author_sort | Noordegraaf, Marina A. |
collection | PubMed |
description | Prescribing dopamine replacement therapy remains the most common approach used by physicians who strive to support persons with Parkinson’s disease. In this viewpoint, we argue that instead of merely prescribing dopamine, healthcare professionals should particularly encourage and enable persons with Parkinson’s disease to draft their own personalized prescription of “hopamine”. The term hopamine is a self-invented neologism representing the uniquely personal set of hopes, desires, experiences, and skills of each individual with a dopamine deficit. As such, the concept of hopamine–as a reflection of the unique personal characteristics of each person with Parkinson’s disease—really supplements that of dopamine–as a reflection of each person’s unique physical characteristics. Whereas a prescription of dopamine replacement medication necessitates the diagnosed individual to lay his or her fate in the hands of medical professionals, adding a personalized dose of hopamine to the therapeutic mix empowers persons to self-manage daily life with Parkinson’s disease. In this viewpoint, we argue that hopamine is a prerequisite for personalized medicine and offer several practical recommendations for how medical professionals can introduce the concept of hopamine in daily clinical practice. |
format | Online Article Text |
id | pubmed-10041418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-100414182023-03-28 Hopamine as Personalized Medicine for Persons with Parkinson’s Disease Noordegraaf, Marina A. van den Berg, Sanne W. Bloem, Bastiaan R. J Parkinsons Dis Commentary Prescribing dopamine replacement therapy remains the most common approach used by physicians who strive to support persons with Parkinson’s disease. In this viewpoint, we argue that instead of merely prescribing dopamine, healthcare professionals should particularly encourage and enable persons with Parkinson’s disease to draft their own personalized prescription of “hopamine”. The term hopamine is a self-invented neologism representing the uniquely personal set of hopes, desires, experiences, and skills of each individual with a dopamine deficit. As such, the concept of hopamine–as a reflection of the unique personal characteristics of each person with Parkinson’s disease—really supplements that of dopamine–as a reflection of each person’s unique physical characteristics. Whereas a prescription of dopamine replacement medication necessitates the diagnosed individual to lay his or her fate in the hands of medical professionals, adding a personalized dose of hopamine to the therapeutic mix empowers persons to self-manage daily life with Parkinson’s disease. In this viewpoint, we argue that hopamine is a prerequisite for personalized medicine and offer several practical recommendations for how medical professionals can introduce the concept of hopamine in daily clinical practice. IOS Press 2023-03-14 /pmc/articles/PMC10041418/ /pubmed/36806516 http://dx.doi.org/10.3233/JPD-230012 Text en © 2023 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Noordegraaf, Marina A. van den Berg, Sanne W. Bloem, Bastiaan R. Hopamine as Personalized Medicine for Persons with Parkinson’s Disease |
title | Hopamine as Personalized Medicine for Persons with Parkinson’s Disease |
title_full | Hopamine as Personalized Medicine for Persons with Parkinson’s Disease |
title_fullStr | Hopamine as Personalized Medicine for Persons with Parkinson’s Disease |
title_full_unstemmed | Hopamine as Personalized Medicine for Persons with Parkinson’s Disease |
title_short | Hopamine as Personalized Medicine for Persons with Parkinson’s Disease |
title_sort | hopamine as personalized medicine for persons with parkinson’s disease |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041418/ https://www.ncbi.nlm.nih.gov/pubmed/36806516 http://dx.doi.org/10.3233/JPD-230012 |
work_keys_str_mv | AT noordegraafmarinaa hopamineaspersonalizedmedicineforpersonswithparkinsonsdisease AT vandenbergsannew hopamineaspersonalizedmedicineforpersonswithparkinsonsdisease AT bloembastiaanr hopamineaspersonalizedmedicineforpersonswithparkinsonsdisease |